Dr. Andrew Manganaro, Chief Medical Officer of Life Line Screening which provides affordable, convenient, community-based screening for vascular disease and related conditions joins eHealth Radio and the Health News & Vascular Disease Channels.
Listen to interview with host Eric Michaels & guest Dr. Andrew Manganaro discuss the following:
- What do you screen for, and why these things?
- What does community-based mean? Why is this important?
- Can you describe one or two of the tests in more detail? For example, the carotid artery test?
- Is your clinical staff, technicians and reviewing physicians, trained as well as hospital staff?
- Do you offer blood tests as well? Which ones?
Dr. Andy Manganaro, MD, FACS, FACC, Chief Medical Officer and National Medical Director
Dr. Manganaro began his tenure at Life Line Screening as a physician reviewer in 2000. His commitment to the company’s overall mission motivated him to take a larger role and in 2005 he became the medical director and Chief Medical Officer, overseeing all aspects of University.clinical quality and development of clinical protocols.
He also directs Life Line Screening’s research collaborations and analysis of its unique database of more than 8 million customers. This research is shedding new light on vascular disease and vascular screening, with a recent paper on abdominal aortic aneurysm screening hailed as “groundbreaking” by those in the vascular community.
Dr. Manganaro has been a practicing vascular and cardiothoracic surgeon for more than 25 years and has cared for more than 10,000 patients with vascular disease and performed more than 5,000 vascular surgeries of every kind. Dr. Manganaro has been a tenured surgeon for more than 20 years at Kettering Hospital and was a founding member of the Governing Board of the Kettering Cardiovascular Institute of Kettering Medical Center. Dr. Manganaro is currently licensed to practice medicine in multiple states and oversees a panel of distinguished reviewing physicians.
Dr. Manganaro graduated medical school from New York University School of Medicine. He graduated Cum Laude and Phi Beta Kappa with a bachelor’s degree from Fordha.